Centra Health Delivers Superior Patient Care with Oracle Cloud Applications

REDWOOD SHORES, Calif., Feb. 13, 2020 /PRNewswire/ — To advance its mission of providing excellent care for life, Centra Health has selected Oracle Cloud Applications. With a complete and integrated suite of applications to manage its finance, procurement, HR and supply chain, Centra Health will be able to increase productivity, improve controls, drive down costs and enhance overall business insights.

Founded in 1987, Centra Health is a regional nonprofit healthcare system with 8,400 staff that serves more than 500,000 people in 70 locations in central and southern Virginia. To continue to deliver on its mission and provide the best possible services for its patients, Centra Health needed to replace its aging and disparate on-premises applications with an integrated suite of applications that would meet its functional needs while driving down costs. After extensive review, Centra selected Oracle Enterprise Resource Planning (ERP) Cloud, Oracle Human Capital Management (HCM) Cloud, and Oracle Supply Chain Management (SCM) Cloud to support its vision for improved, affordable healthcare.

“When determining the appropriate vendor to support our business, we used a multidisciplinary process to ensure our needs were accurately quantified and comprehensively vetted,” said Tom Lawton, vice president and chief resource officer at Centra Health. “Oracle surfaced as the ERP vendor that checked all of the boxes, and our leadership felt confident that Oracle could support both our current and future needs. We are also anticipating additional value from the relationship with Oracle by having a common platform across our HR, finance, and supply chain operations.”

With Oracle ERP Cloud, Oracle HCM Cloud, and Oracle SCM Cloud, Centra Health will be able to take advantage of the cloud to break down organizational silos, standardize processes, and manage data from its finance, supply chain and HR teams on a single integrated cloud platform. In addition, by providing a common user interface across all functional areas, Oracle Cloud Applications will help Centra Health increase employee engagement, collaboration, and performance. To drive better business results and ensure its team stays focused on providing the best possible patient care, Centra Health will also leverage Oracle’s embedded healthcare and technology expertise, best practices, and third-party partnerships.

“Whether its evolving regulations, the shifting payer-provider dynamic, advances in medicine, or increasing customer expectations, hospitals are struggling to stay ahead of accelerating change,” said Rajan Krishnan, group vice president of product development, Oracle. “Oracle Cloud Applications will help Centra Health outpace all of this change and stay ahead of customer expectations by providing proven, best-of-breed applications across every business function.”

Additional Resources

About Oracle
The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/centra-health-delivers-superior-patient-care-with-oracle-cloud-applications-301003575.html

SOURCE Oracle

Staff

Recent Posts

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

15 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

15 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

15 hours ago